MARSHALL WACE, LLP

Position in ABBV — AbbVie Inc.

CIK 1318757 LONDON, X0

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$752,532,439

+$752,301,683 QoQ

Shares Held

2,990,512

+281757.9% QoQ

Ownership

0.169%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#61

of 4,150 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Dec 31, 2023

CallValue

$29,180,851

CallShares

188,300

PutValue

$16,426,820

PutShares

106,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. ABBV ranks #2 (32.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,989,537	$759,252,709
2	ABBV	AbbVie Inc. This page	2,990,512	$752,532,439
3	LLY	ELI LILLY & Co	334,637	$401,373,688
4	AZN	Astrazeneca PLC	841,164	$159,501,517
5	NVO	Novo Nordisk A S	1,707,104	$81,838,564
6	NVS	Novartis AG	330,061	$51,727,159
7	AMGN	Amgen Inc	99,402	$35,995,452
8	GILD	Gilead Sciences, Inc.	204,677	$25,858,892

All Filings in ABBV

Export CSV

37 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$752,532,439	2,990,512	+281757.9%	Shares	Other	2026-08-13
2026-03-31	$230,756	1,061	-99.8%	Shares	Other	2026-05-15
2025-12-31	$148,518,500	650,000	-49.1%	Shares	Other	2026-02-13
2025-09-30	$295,715,246	1,277,167	-7.4%	Shares	Other	2025-11-13
2025-06-30	$256,032,161	1,379,335	+470.5%	Shares	Other	2025-08-13
2025-03-31	$50,659,211	241,787	-84.7%	Shares	Other	2025-05-15
2024-12-31	$280,214,240	1,576,895	+18.6%	Shares	Other	2025-02-13
2024-09-30	$262,484,294	1,329,169	+50.0%	Shares	Other	2024-11-14
2024-06-30	$151,952,140	885,915	-47.2%	Shares	Other	2024-08-14
2024-03-31	$305,430,502	1,677,268	-47.1%	Shares	Other	2024-05-15
2023-12-31	$29,180,851	188,300	+159.0%	Call	Other	2024-02-14
2023-12-31	$16,426,820	106,000	+273.2%	Put	Other	2024-02-14
2023-12-31	$491,726,008	3,173,040	-18.8%	Shares	Other	2024-02-14
2023-09-30	$582,301,398	3,906,490	+333.0%	Shares	Other	2023-11-14
2023-06-30	$9,794,871	72,700	+1072.6%	Call	Other	2023-08-14
2023-06-30	$3,826,332	28,400	+456.9%	Put	Other	2023-08-14
2023-06-30	$121,562,297	902,266	+15.6%	Shares	Sole	2023-08-14
2023-03-31	$124,435,299	780,795	+4493.2%	Shares	Other	2023-05-15
2023-03-31	$988,094	6,200	-18.4%	Call	Other	2023-05-15
2022-12-31	$2,747,208	16,999	-63.2%	Shares	Other	2023-02-14
2022-12-31	$824,211	5,100	-43.3%	Put	Other	2023-02-14
2022-09-30	$1,019,996	7,600	+2433.3%	Call	Other	2022-11-14
2022-09-30	$6,197,549	46,178	-89.0%	Shares	Other	2022-11-14
2022-09-30	$1,207,890	9,000	+1400.0%	Put	Other	2022-11-14
2022-06-30	$64,571,030	421,592	-64.9%	Shares	Other	2022-08-15
2022-03-31	$194,520,490	1,199,929	+282.5%	Shares	Other	2022-05-16
2021-12-31	$42,472,406	313,681	+966.8%	Shares	Other	2022-02-14
2021-09-30	$3,171,701	29,403	+508.1%	Shares	Sole	2021-11-15
2021-09-30	$32,361	300	-98.1%	Call	Sole	2021-11-15
2021-06-30	$544,614	4,835	-97.3%	Shares	Sole	2021-08-13
2021-03-31	$64,932	600	—	Put	Sole	2021-05-17
2021-03-31	$1,720,698	15,900	—	Call	Sole	2021-05-17
2021-03-31	$19,062,303	176,144	-37.5%	Shares	Sole	2021-05-17
2020-12-31	$30,185,762	281,715	-45.5%	Shares	Sole	2021-02-16
2020-09-30	$45,297,431	517,153	-59.9%	Shares	Sole	2020-11-16
2020-06-30	$126,585,437	1,289,320	+120.4%	Shares	Sole	2020-08-13
2020-03-31	$44,571,226	585,001	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.